LTR Pharma Logo

LTR Pharma

LTR Pharma is a Clinical Stage Biopharmaceutical Company

SPONTAN® (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction

About Erectile Dysfunction

Erectile Dysfunction (ED) is a condition in which you are unable to get or keep an erection firm enough for satisfactory sexual intercourse. ED can be a short-term or long-term problem.

Our Solution

SPONTAN® provides on demand delivery and faster effect. A lower dose provides less systematic exposure and reduced side effects

Commercialisation

LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) SPONTAN® with fast-track US NDA Filing within two years

322M

worldwide expected cases by 2025

10

minute effectiveness

$7.10B

projected global market value 2024

Global Market Need

ED is a serious and common medical problem with significant impacts to both physical and psychological health
ED has been identified as a major factor in relationship breakdown (20%). The worldwide prevalence doubled in the last 30 years and is expected to increase to 322 million in 2025.

ON DEMAND
SOLUTION

LTR Pharma Couple

RAPID ONSET
ACTION

BRING BACK
SPONTANEITY

Conversation Series | Treatments for ED | Dr Tom Silva

The third video from our Conversation Series with Dr Thomas Silva is now live. Dr Silva is a specialist GP and University of Queensland lecturer with unique expertise in erectile dysfunction treatments, including experience with complex post-prostate cancer cases. In this video, Dr Silva provides a comprehensive overview of current

Read More »

Conversation Series | ED Discussions in Primary Care | Dr Tom Silva

The second video from our Conversation Series with Dr Thomas Silva is now live. Dr Silva is a specialist GP and University of Queensland lecturer who brings unique expertise in erectile dysfunction treatment, including experience with complex post-prostate cancer cases. In this conversation, Dr Silva shares his clinical experience with

Read More »

The Medical Republic | Erectile Dysfunction Telehealth Platform to Launch

LTR Pharma’s exciting new joint venture with Restorative Sexual Health Clinic (RSHC) to launch an online healthcare platform dedicated to men’s health has been featured in The Medical Republic. Here’s an excerpt: ‘𝘔𝘦𝘭𝘪𝘴𝘴𝘢 𝘏𝘢𝘥𝘭𝘦𝘺 𝘉𝘢𝘳𝘳𝘦𝘵𝘵, 𝘧𝘰𝘶𝘯𝘥𝘦𝘳 𝘰𝘧 𝘵𝘩𝘦 𝘙𝘚𝘏𝘊 𝘴𝘢𝘪𝘥: “𝘛𝘩𝘪𝘴 𝘱𝘢𝘳𝘵𝘯𝘦𝘳𝘴𝘩𝘪𝘱 𝘢𝘭𝘪𝘨𝘯𝘴 𝘱𝘦𝘳𝘧𝘦𝘤𝘵𝘭𝘺 𝘸𝘪𝘵𝘩 𝘰𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘵𝘰 𝘱𝘳𝘰𝘷𝘪𝘥𝘦 𝘤𝘰𝘮𝘱𝘳𝘦𝘩𝘦𝘯𝘴𝘪𝘷𝘦,

Read More »

Special Access Scheme

SPONTAN may be prescribed to eligible patients under the TGA’s Special Access Scheme. For more information, please register your details via our online form.

Receive our latest news and investor updates

By entering your email address you are agreeing to our privacy policy.